LeddarTech wins against Phantom Intelligence in patent violation case
By Nikita Chaurasia  Date: 2019-07-31

LeddarTech wins against Phantom Intelligence in patent violation case
  • Reportedly, in 2015, the company challenged Phantom Intelligence for illegal use of its patented LiDAR sensing technology.
  • Post the 2015 court hearing, Phantom Intelligence became the customer of LeddarTech.

Canada based LeddarTech recently announced its victory in patent breach case against Phantom Intelligence at the Federal Court of Canada. 

As per credible sources, LeddarTech had earlier challenged Phantom Intelligence for an unethical use of its patented Light Detection and Ranging (LiDAR) sensing technology. The technology has been claimed to be reserved by Canadian Patent No. 2,710,212 titled “Detection & Ranging Methods & Systems” which talks about the schemes and approaches for obtaining an optical signal and converting it into a digital trace.

The patent is a principal driver of the company’s time-honored intellectual property and is carried out in all its LiDAR sensing products positioned in the Advanced Driver-Assistance Systems and applications in the mobility sectors. Reportedly, after the court process, Phantom Intelligence has agreed to become a customer of the company.

Pierre Olivier, CTO at LeddarTech was reportedly quoted stating that the company is extensively proud of its years of pioneering the innovations in LiDAR technology. It has always been confident of attaining success in defense of its intellectual property and promises to be attentive in safeguarding it.

LeddarTech understands the significant contributions of its engineers and scientists to its intellectual property and aims to continue monitoring for possible breaches of its patented LiDAR sensing technology.

The settlement amount and terms & conditions regarding the deal have been kept confidential by both the parties.

LeddarTech, headquartered in Canada and established in 2007, is an industry leader in delivering the most adaptable, scalable auto and mobility LiDAR platform built on a unique LeddarEngine consisting a part of automotive-grade suite, and functional safety certified SoCs working in an arrangement with LeddarSP signal processing software.

LeddarTech works progressively towards improving the safety and quality of life for the travelers, workers, and other mobility industry professionals.

Source credit: https://leddartech.com/leddartech-successfully-defends-lidar-intellectual-property-phantom-intelligence/

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Fragomen acquires SimpleCitizen to reinforce its immigration services
Fragomen acquires SimpleCitizen to reinforce its immigration services
By Nikita Chaurasia

In a recent turn of events, Fragomen, Del Rey, Bernsen & Loewy, LLP, a leading corporate immigration law company has reportedly joined hands with SimpleCitizen Inc. to form Fragomen Technologies Inc., a new subsidiary which will provide a combina...

Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
By Nikita Chaurasia

Solar project development and asset management major, Nautilus Solar Energy LLC, has reportedly announced its acquisition of two solar portfolios in Rhode Island and Oregon amounting to a total of nearly 17 MW from leading solar energy developer, Pin...

Locate Bio obtains multiple late stage orthobiologics assets from RCSI
Locate Bio obtains multiple late stage orthobiologics assets from RCSI
By Nikita Chaurasia

Regenerative medicine major, Locate Bio, has reportedly announced its in-licensing of several late stage orthobiologics assets from the RCSI University of Medicine and Health Sciences. Sources state that the technologies created by the RCSI Tissue E...

Roche acquires Inflazome to gain control over inflammatory treatments
Roche acquires Inflazome to gain control over inflammatory treatments
By Nikita Chaurasia

In a recent turn of events, Swiss healthcare giant, F. Hoffmann-La Roche AG has reportedly acquired an Irish biotech firm Inflazome Ltd. for approximately USD 451 million (€380 million). As per the agreement, Roche will acquire complete rights ...

Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
By Nikita Chaurasia

Innovent Biologics Inc., in collaboration with American pharmaceutical giant Eli Lilly and Company, have reportedly announced that the biomarker results of ORIENT-11 trials which were displayed during a mini verbal presentation at ESMO (European Soci...